Literature DB >> 28043219

Rise in invasive serogroup W meningococcal disease in Australia 2013-2015.

Nicolee V Martin1, Katherine S Ong2, Benjamin P Howden3, Monica M Lahra4, Stephen B Lambert5,6, Frank H Beard7, Gary K Dowse8, Nathan Saul9.   

Abstract

Since 2013, there has been an increase in the number of notified cases of invasive meningococcal disease (IMD) due to serogroup W (MenW) in Australia. In response to this observed increase, the Communicable Diseases Network Australia convened a working group in 2015 to collate and analyse the epidemiology of MenW disease nationally. Enhanced surveillance data collected by jurisdictions were collated and analysed, and whole genome sequencing (WGS) of MenW isolates assessed the genomic relatedness of strains between 2012 and 2015. This report describes that epidemiology. Since 2013, the incidence and proportion of MenW has increased in Australia, rising from an average of 2% of all IMD cases annually (range 0% to 5%) between 1991 and 2012; to 8% (12/149) of cases in 2013, 10% (17/169) in 2014, and 19% (34/182) in 2015. Victoria has been the main affected state, with 50% (17/34) of national cases in 2015. MenW has affected older populations, with a median age between 2003 and 2015 being 44 years. During this period, case fatality was 10.7% (17/159), 2.3 times higher than for all IMD serogroups combined (4.7%, 173/3720). There were 7 deaths due to MenW in 2015 (CFR 21%). WGS has found the majority of Australian isolates cluster within a group of W:P1.5,2:F1-1:ST11 isolates from the United Kingdom and South America, regions where rapid spread and endemic transmission has occurred since 2009. The recent increase in incidence of MenW in Australia is evolving and is being closely monitored. Lessons learned from the international experience will be important in informing the public health response.

Entities:  

Mesh:

Year:  2016        PMID: 28043219

Source DB:  PubMed          Journal:  Commun Dis Intell Q Rep        ISSN: 1447-4514


  16 in total

1.  Increase in Neisseria meningitidis serogroup W invasive disease in Canada: 2009-2016.

Authors:  Rsw Tsang; L Hoang; G J Tyrrell; G Horsman; P Van Caeseele; F Jamieson; B Lefebvre; D Haldane; R R Gad; G J German; G Zahariadis
Journal:  Can Commun Dis Rep       Date:  2017-07-06

Review 2.  Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines.

Authors:  Rodolfo Villena; Marco Aurelio P Safadi; María Teresa Valenzuela; Juan P Torres; Adam Finn; Miguel O'Ryan
Journal:  Hum Vaccin Immunother       Date:  2018-04-30       Impact factor: 3.452

Review 3.  Challenges and opportunities for meningococcal vaccination in the developing world.

Authors:  Rouba Shaker; Danielle Fayad; Ghassan Dbaibo
Journal:  Hum Vaccin Immunother       Date:  2018-02-23       Impact factor: 3.452

4.  Increase in ST-11 serogroup W Neisseria meningitidis invasive meningococcal disease in Canada, 2016-2018.

Authors:  R S Tsang; L Hoang; G J Tyrrell; J Minion; P Van Caeseele; J V Kus; B Lefebvre; D Haldane; R Garceau; G German; G Zahariadis; B Hanley
Journal:  Can Commun Dis Rep       Date:  2019-06-06

5.  Clonal Expansion of New Penicillin-Resistant Clade of Neisseria meningitidis Serogroup W Clonal Complex 11, Australia.

Authors:  Shakeel Mowlaboccus; Keith A Jolley; James E Bray; Stanley Pang; Yung Thin Lee; Jane D Bew; David J Speers; Anthony D Keil; Geoffrey W Coombs; Charlene M Kahler
Journal:  Emerg Infect Dis       Date:  2017-08-15       Impact factor: 6.883

6.  The Clinical Picture and Severity of Invasive Meningococcal Disease Serogroup W Compared With Other Serogroups in the Netherlands, 2015-2018.

Authors:  Anna D Loenenbach; Arie van der Ende; Hester E de Melker; Elisabeth A M Sanders; Mirjam J Knol
Journal:  Clin Infect Dis       Date:  2020-05-06       Impact factor: 9.079

7.  Whole genome sequencing of Neisseria meningitidis W isolates from the Czech Republic recovered in 1984-2017.

Authors:  Michal Honskus; Zuzana Okonji; Martin Musilek; Jana Kozakova; Pavla Krizova
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

8.  Phase Variation of NadA in Invasive Neisseria meningitidis Isolates Impacts on Coverage Estimates for 4C-MenB, a MenB Vaccine.

Authors:  Luke R Green; Jay Lucidarme; Neelam Dave; Hannah Chan; Stephen Clark; Ray Borrow; Christopher D Bayliss
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

9.  Emergence of Localized Serogroup W Meningococcal Disease in the United States - Georgia, 2006-2016.

Authors:  Ashley E Moore; Jessica R MacNeil; Xin Wang; Sandeep J Joseph; Lauren Lorentzson; Stepy Thomas; Amy Tunali; Tonia Parrott; Monica M Farley; Melissa Tobin-D'Angelo
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-08-17       Impact factor: 17.586

10.  Case Manifestations and Public Health Response for Outbreak of Meningococcal W Disease, Central Australia, 2017.

Authors:  Eva L Sudbury; Siobhan O'Sullivan; David Lister; Deepa Varghese; Keshan Satharasinghe
Journal:  Emerg Infect Dis       Date:  2020-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.